Waystar Holding Corp. logo WAY - Waystar Holding Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 16
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $35.00 DETAILS
HIGH: $43.00
LOW: $27.00
MEDIAN: $35.00
CONSENSUS: $35.00
UPSIDE: 47.74%

Stock News

Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

Report finds that clients using multiple Waystar capabilities achieve the strongest outcomes, highlighting the value of a single, connected platform LEHI, Utah and LOUISVILLE, Ky., July 21, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it earned an overall "A" satisfaction score among revenue cycle management (RCM) platform vendors in KLAS Research's inaugural Revenue Cycle Management Suites 2026 report.

Jul 21, 2026 01:00 PM prnewswire.com
Kaskela Law LLC Announces Investigation of Waystar Holding Corp. (WAY) and Encourages Long-Term WAY Shareholders to Contact the Firm

Kaskela Law LLC Announces Investigation of Waystar Holding Corp. (WAY) and Encourages Long-Term WAY Shareholders to Contact the Firm

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating Waystar Holding Corp. (Nasdaq: WAY) (“Waystar”) on behalf of the company's current shareholders. The investigation seeks to determine whether Waystar and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Waystar shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional in.

Jul 16, 2026 04:00 AM businesswire.com
Waystar: Silently Taking Over Healthcare Billing

Waystar: Silently Taking Over Healthcare Billing

Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.

Jun 18, 2026 01:50 AM seekingalpha.com
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.

Jun 09, 2026 03:00 AM prnewswire.com
Baron Discovery Fund Q1 2026: Who Moved The Needle

Baron Discovery Fund Q1 2026: Who Moved The Needle

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. Advanced Energy Industries, Inc.'s stock rose during the quarter as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. Baron Discovery Fund sold its investment in Intapp, Inc. in the quarter as the team believes that its other software holdings have better overall competitive advantages.

Jun 07, 2026 09:35 PM seekingalpha.com
Waystar: Revised Guidance Does Not Imply Demand Weakness

Waystar: Revised Guidance Does Not Imply Demand Weakness

Waystar remains a buy as Q1 results confirm robust demand, with provider solutions leading and AI integration strengthening the platform story. WAY's Q1 revenue grew 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, highlighting strong customer engagement. Patient payment solution headwinds stem from a faster shift to digital, seen as a near-term timing issue rather than a structural demand problem.

May 12, 2026 01:16 AM seekingalpha.com
Waystar Named to TIME100 Most Influential Companies

Waystar Named to TIME100 Most Influential Companies

Wins TIME Impact in AI Award for purpose-built innovation in healthcare LEHI, Utah and LOUISVILLE, Ky., May 5, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named to the TIME100 Most Influential Companies list and recognized as the TIME Impact in AI award winner for delivering proven outcomes across the healthcare revenue cycle.

May 05, 2026 12:00 PM prnewswire.com

Price Targets